MedPath
TGA Approval

BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (190718)

190718

BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle

GlaxoSmithKline Australia Pty Ltd

August 14, 2013

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/4139b7eaa3057cc98b3e5f2f8914d527.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/4945443148588198a74ba8e839bf7ac7.pdf

Active Ingredients

Neisseria meningitidis Group B Factor H Binding Protein fusion protein

Neisseria meningitidis Group B Neisseria Adhesin A protein

Neisseria meningitidis serogroup B outer membrane vesicles

Neisseria meningitidis Group B Neisseria Heparin Binding Antigen fusion protein

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (190718) - TGA 批准文号 | MedPath